Valiant Laboratories Limited (NSEI: VALIANTLAB)
Health Care · Pharmaceuticals · IN
Rs119.80
-4.22% today · +44.4% 1Y
Valiant Laboratories Limited (NSEI: VALIANTLAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $67.23M and employs 84 people.
Over the last twelve months the share price has gained 44.4%, trading between 49.51 and 132.25.
Tweenvest scores Valiant Laboratories Limited across four factors: quality 74/100, value 60/100. Its strongest factor is quality.
VALIANTLAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $67.23M
- Revenue (TTM)
- $32.36M
- P/E
- 40.63
- EPS
- 2.95
- Dividend yield
- —
- Beta (5Y)
- 0.92
- 52-week high
- Rs132.25
- 52-week low
- Rs49.51
- Avg volume (3M)
- —
- Shares outstanding
- 54.31M
- Employees
- 84
- Next earnings
- —
About Valiant Laboratories Limited
Valiant Laboratories Limited, an India-based company, specializes in the production of active pharmaceutical ingredients (APIs) and bulk drugs, serving both domestic and international markets. Its primary product is paracetamol, manufactured in various grades that meet Indian, British, European, and United States pharmacopoeia standards. This crucial compound is utilized in treatments for common ailments such as headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. Beyond pharmaceuticals, the company also supplies specialty chemicals. Originally established in 1980 and headquartered in Mumbai, India, the firm rebranded as Valiant Laboratories Limited in August 2021, having previously operated under the name Bharat Chemicals. It functions as a subsidiary of Dhanvallabh Ventures LLP.
- ISIN
- INE0JWS01017
- Founded
- 1980
- Listed since
- Oct 6, 2023
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD.KOSDAQ: A330350 | $69.12M | ₩7,040.00 | -2.90% |
| NeOnc Technologies Holdings, Inc.NasdaqGM: NTHI | $69.10M | $2.90 | +4.32% |
| Syngen Biotech Co.,Ltd.TPEX: 8279 | $68.57M | NT$80.90 | +1.76% |
| Y.S.P. Southeast Asia Holding BerhadKLSE: YSPSAH | $68.04M | RM1.96 | +1.55% |
| Johnson Chemical Pharmaceutical Works Co., Ltd.TPEX: 4747 | $66.40M | NT$23.35 | +1.74% |
| Wakamoto Pharmaceutical Co.,Ltd.TSE: 4512 | $66.14M | ¥301.00 | +3.44% |
| Kukje Pharma Co., Ltd.KOSE: A002720 | $64.68M | ₩4,270.00 | +30.18% |
| Kubota Pharmaceutical Holdings Co., Ltd.TSE: 4596 | $64.51M | ¥63.00 | -5.97% |
Figures last refreshed Oct 11, 2026.